Manish Goel - SEBI Registered Investment Advisor

About Manish Goel

SEBI Registered Investment Advisor • Chartered Accountant

383 Articles Published

Manish Goel is a Chartered Accountant, SEBI-registered Investment Advisor, and founder of Multibagger Shares. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.

April 18, 2026
Bar chart: Segment Reporting values from FY20 to FY25, with FY20=28, FY21=26, FY22=22, FY23=18, FY24=14, FY25=11; FY25 bar is green.

Segment Reporting: The Hidden Disclosure in Indian Annual Reports That Reveals True Business Quality — How Smart Value Investors Decode Ind AS 108 to Find Multibaggers the Crowd Misses

📅 Published 18 April 2026 (Saturday) Most Indian investors read the headline profit, glance at the EPS, and close the annual report. They never scroll to […]
April 18, 2026
Bar chart showing yearly contingent liabilities from FY20 to FY25, with FY25 at 11 highlighted in green (FY20 28, FY21 26, FY22 22, FY23 18, FY24 14).

Contingent Liabilities

Titan Biotech's FY25 contingent liability disclosure stands at just ₹7.78 Cr — a forensic gold standard 5.08% of net worth versus the 15–50% Indian small-cap norm. Here is the deep-dive every value investor must read.
April 18, 2026
Cement sector analysis framework grid with four colored blocks: Trader (gray), Compounder (green), Drift (light gray), Speculator (orange) on a dark blue background.

Cement Sector Analysis Framework: The 8-Factor Checklist Every Indian Value Investor Must Use to Separate Multibagger Cement Stocks from Value Traps in India’s ₹2 Lakh Crore Super-Cycle

A complete 8-factor framework for analysing Indian cement stocks — capacity, region, EBITDA per tonne, balance sheet, and consolidation theme. Live data, no F&O noise, real multibagger hunting.
April 17, 2026
Bar chart titled Normalized Earnings Analysis showing FY20–FY25; FY25 is green with value 16, others show 38, 32, 26, 22, 19.

Normalized Earnings Analysis: How to See Through Cyclical Noise and Find the True Earning Power of Indian Stocks — The Professional Valuation Technique Every Serious Value Investor Must Master

Stop valuing companies on volatile reported earnings. Master the five-step normalization framework that Warren Buffett, Bruce Greenwald, and Howard Marks all use — and see why Titan Biotech's consistent earnings power already passes the test.
+91-8448836436